sec filing
LP
NASDAQ · LPCN
Lipocine Inc.
Healthcare · Biotechnology
$2.11
Up+$0.05 (+2.43%)
Updated Aug 15, 2026, 4:03 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 17.11M
- P/E ratio
- -3.79
- Dividend yield
- 0.00%
- 52-week range
- $1.81 – $9.30
- Volume
- 31.39K
- Avg. volume
- 43.6K
Price performance
LPCN price history
1M range · 21 trading sessions · Daily adjusted prices
LPCN closed at $2.11 after 21 trading sessions, down 5.38% for the selected period.
- Last close
- $2.11
- Period change
- -5.38%
- Period low
- $2.06
- Period high
- $2.23
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $2.10 | $2.18 | $2.07 | $2.11 | 31.39K |
| Aug 13, 2026 | $2.07 | $2.2237 | $2.04 | $2.06 | 23.73K |
| Aug 12, 2026 | $2.11 | $2.13 | $2.02 | $2.06 | 48.97K |
| Aug 11, 2026 | $2.10 | $2.1599 | $2.09 | $2.09 | 13.32K |
| Aug 10, 2026 | $2.16 | $2.21 | $2.10 | $2.10 | 41.49K |
| Aug 7, 2026 | $2.26 | $2.26 | $2.12 | $2.13 | 33.86K |
| Aug 6, 2026 | $2.14 | $2.18 | $2.08 | $2.13 | 37.01K |
| Aug 5, 2026 | $2.19 | $2.2605 | $2.15 | $2.17 | 56.2K |
| Aug 4, 2026 | $2.13 | $2.2199 | $2.06 | $2.13 | 131.36K |
| Aug 3, 2026 | $2.239 | $2.239 | $2.03 | $2.11 | 91.27K |
| Jul 31, 2026 | $2.16 | $2.16 | $2.10 | $2.12 | 29.43K |
| Jul 30, 2026 | $2.05 | $2.1999 | $2.05 | $2.11 | 58.35K |
| Jul 29, 2026 | $2.13 | $2.1499 | $2.06 | $2.07 | 38.27K |
| Jul 28, 2026 | $2.27 | $2.27 | $2.12 | $2.14 | 32.07K |
| Jul 27, 2026 | $2.09 | $2.16 | $2.09 | $2.14 | 29.43K |
| Jul 24, 2026 | $2.23 | $2.23 | $2.08 | $2.08 | 35.75K |
| Jul 23, 2026 | $2.20 | $2.22 | $2.17 | $2.19 | 22.04K |
| Jul 22, 2026 | $2.232 | $2.25 | $2.18 | $2.23 | 30.91K |
| Jul 21, 2026 | $2.15 | $2.2541 | $2.15 | $2.19 | 17.1K |
| Jul 20, 2026 | $2.24 | $2.24 | $2.15 | $2.15 | 31.39K |
| Jul 17, 2026 | $2.27 | $2.29 | $2.23 | $2.23 | 20.67K |
Latest LPCN news
The latest Smart Investors Daily articles mentioning LPCN.
Stock researchResearch & News · Competitors
Loading stock research…

